US Stock MarketDetailed Quotes

ARMP Armata Pharmaceuticals

Watchlist
  • 1.950
  • -0.030-1.52%
Close Dec 20 16:00 ET
70.56MMarket Cap-1.70P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Dec 19 06:06
    NEWS
    $Armata Pharmaceuticals (ARMP.US)$
    Armata Pharmaceuticals Announces Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
    Thursday, 19th December at 7:00 am
    Results demonstrate that inhaled AP-PA02 provides a durable reduction of Pseudomonas aeruginosa in the lung, with a favorable safety and tolerability profile
    LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Armata Pharmaceutic...
    Jaguar8
    Jaguar8
    Nov 14 15:33
    13D
    $Armata Pharmaceuticals (ARMP.US)$
    Armata Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Innoviva, Inc(85.2%),Innoviva Strategic Opportunities LLC(62.1%)
    Jaguar8
    Jaguar8
    Nov 12 06:06
    NEWS
    $Armata Pharmaceuticals (ARMP.US)$
    Armata Pharmaceuticals Announces the Completion of Enrollment of its Phase 1b/2a diSArm Study Evaluating Intravenous AP-SA02 as a Potential Treatment for Staphylococcus aureus Bacteremia
    Topline data anticipated in Q1 2025 to support potential initiation of a pivotal bacteremia efficacy trial in 2025
    LOS ANGELES, Nov. 12, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology compan...
    Trytosaveabit
    Trytosaveabit
    Aug 14 05:42
    Watching for data!
    $Armata Pharmaceuticals (ARMP.US)$         The last patient had their final follow-up visit on August 7th, in its Tailwind Phase 2 clinical study of inhaled AP-PA02 in patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and chronic pulmonary Pseudomonas aeruginosa (P. aeruginosa) infection. Armata anticipates topline data from the Tailwind study in the second half of 2024.
    2
    Trytosaveabit
    Trytosaveabit
    Jul 30 06:06
    Update
    $Armata Pharmaceuticals (ARMP.US)$ Reuters· 5 mins ago
    Armata Pharmaceuticals Receives $5.25 Million of Additional Non-Dilutive Grant Funding From the U.S. Department of Defense to Support Ongoing Disarm Clinical Trial of AP-SA02
Read more
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Intchains Group
ICG
+88.60%
BIGG DIGITAL ASSETS INC
BBKCF
+16.25%
NEPTUNE DIGITAL ASSETS CORP
NPPTF
+13.51%
Bitdeer Technologies
BTDR
+12.95%
FRMO CORP
FRMO
+8.72%

Unlock the Full List